首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human IL2RA Recombinant Antibody(Daclizumab)

Anti-Human IL2RA Recombinant Antibody(Daclizumab)

产品编号

YR1002

别名

科研级Daclizumab, Anti-IL2RA Recombinant Antibody, Research Grade Daclizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级Daclizumab, Anti-IL2RA Recombinant Antibody, Research Grade Daclizumab
Catalog NumberYR1002
Molecular NameDaclizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundDaclizumab (trade name Zinbryta) is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis (MS). Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells.
CAS Number152923-56-3
ApplicationELISA, Neut, IF, IP, FCM, FuncS, MRI
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
Molecular Weight142.61 kDa
TargetIL2RA[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价